Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Remtec Search

The specialist European Medical Device and Life Science recruitment company, working internationally to assist candidates and clients from across the world. Remtec offers 2 main services: Executive search and Contingency selection focusing on sales, marketing and technical roles. Our extensive experience, combined with proven processes, allows us to offer an unprecedented service to employers seeking top quality candidates and to candidates seeking top quality employers.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Digital communications, Medical education, Recruitment and career development

Company Details

Remtec Search
Remtec Search and Selection Ltd, Registered Office, Breaks House, Mill Court, Cambridge, CB22 5LD, United Kingdom
+44 (0)1223 550 860
Contact Remtec Search
Website

 Latest Content from PMHub 

Living with Crohn’s disease: a patient perspective

White Papers and Resources | November 24, 2016 | Blue Latitude Health

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for...

Lucid win PMEA Support Agency of the Year 2016

Press Releases | November 24, 2016 | Lucid Group Communications Limited

Last night the Lancaster London Hotel hosted the annual PMEA awards. These awards recognise and commend companies and programmes demonstrating excellence, best practice and innovation in improving patient outcomes on...

Case Study: Understanding the patient journey and addiction treatment pathways

White Papers and Resources | November 23, 2016 | Inizio

Our client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and...

Research Partnership has published a new Living with Chronic Pain market report for 2016

White Papers and Resources | November 23, 2016 | Inizio

Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients...

Nutraceuticals: Rich in Potential

White Papers and Resources | November 23, 2016 | Inizio

Published in eyeforpharma October 2016 by Marc Yates

Case Study: Qualitative research with payers in low and middle income countries

White Papers and Resources | November 23, 2016 | Inizio

Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in...

Webinar – Immuno-oncology’s Evolution: Implications for Pharma Market Researchers

White Papers and Resources | November 23, 2016 | Inizio

In association with PMGroup

Case study: Leveraging Market Research Data to Inform Healthcare Providers and the Community

White Papers and Resources | November 23, 2016 | Inizio

Our client wanted to understand why uptake of HPV vaccination in the Asia-Pacific region was limited.  In order to help increase uptake, they wanted to publish the market research findings...

Towards a culture of evaluation and evidence-based decision making in global health

White Papers and Resources | November 23, 2016 | Inizio

Reflections on THET Conference 2016: Evidence, Effectiveness & Impact

Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016

White Papers and Resources | November 23, 2016 | Inizio

Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including...